Evolent Health ( NYSE:EVH – Get Free Report ) is one of 93 public companies in the “Healthcare Technology” industry, but how does it contrast to its peers? We will compare Evolent Health to related businesses based on the strength of its analyst recommendations, dividends, profitability, institutional ownership, risk, valuation and earnings.
Volatility and Risk
Evolent Health has a beta of 1.03, indicating that its share price is 3% more volatile than the S&P 500. Comparatively, Evolent Health’s peers have a beta of 1.11, indicating that their average share price is 11% more volatile than the S&P 500.
Get Evolent Health alerts:
Analyst Ratings
This is a breakdown of current ratings and target prices for Evolent Health and its peers, as provided by MarketBeat.com.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Evolent Health 1 4 11 0 2.62
Evolent Health Competitors 451 1532 2741 89 2.51
Evolent Health presently has a consensus target price of $6.11, indicating a potential upside of 32.62%. As a group, “Healthcare Technology” companies have a potential upside of 44.71%. Given Evolent Health’s peers higher probable upside, analysts plainly believe Evolent Health...